 Hence, targeting cytokines and their receptors is an effective means of treating such disorders.Type I and II cytokine receptors associate with Janus family kinases (JAKs) to affect intracellular signaling.Cytokines including interleukins, interferons and hemopoietins activate the Janus kinases, which associate with their cognate receptors.